# ACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee Arthroplasty

> **NCT07677215** · NA · NOT_YET_RECRUITING · sponsor: **Poznan University of Medical Sciences** · enrollment: 120 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** Ropivacaine 0.2% Injectable Solution
- **DRUG:** Dexamethasone
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT07677215
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07677215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07677215, "ACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee Arthroplasty". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07677215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*